Aug 7 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 11 mln 18 mln 385 mln
(-37.7 pct) (-91.9 pct) (+300.7 pct)
Operating loss 544 mln loss 609 mln loss 1.21
Recurring loss 554 mln loss 623 mln loss 1.20
Net loss 551 mln loss 629 mln loss 1.20
EPS loss 9.27 yen loss 12.82 yen loss 19.95 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T